PMV Pharma - PMVP Quarterly EPS earnings growth

Corporate company logo of PMV Pharmaceuticals, Inc. (PMVP)

The absence of current sales makes the pricing power of PMV Pharmaceuticals (PMVP) dependent on the results of p53 inhibitor trials. This daily price action of quarterly EPS on the GURU.Markets platform chart reflects market expectations, where the value of -31.10 expresses the metric level. The company's revenues rely on the future commercialization of treatments for solid tumors, although the fierce battle for leadership in this niche creates critical risks.

pmvpharma.com (PMVP) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/16/2026

Analytical breakdowns for PMV Pharmaceuticals

- share price and consensus valuation forecast:
Fundamental company valuation:pmvpharma.com - PMVP
Flagship merchandise of pmvpharma.com

This indicator measures the year-over-year dynamics of net earnings per share on a quarterly basis, reflecting the issuer's margin sensitivity to macroeconomic conditions and interest rates. For PMV Pharmaceuticals (PMVP), which develops unique methods for p53 protein reactivation, the quarterly earnings per share chart serves as a marker for R&D investment efficiency and the absence of pricing pressure from competitors.

Analysis of competing companies

GMAB (Genmab) - Year-over-year net earnings per share growth for the last 12 months|EXEL: Year-over-year earnings per share growth rate for the last twelve months|NUVL (Nuvalent Therapeutics) - Quarterly EPS earnings growth|Quarterly EPS earnings growth kymeratx.com|Year-over-year earnings per share growth for the last twelve months IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORIC (ORIC Pharmaceuticals Inc)|Net earnings per share growth for the trailing year Relay Pharma|Nurix Therapeutics Inc - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Tyra Biosciences|VSTM (Verastem, Inc.) - Year-over-year net earnings per share growth for the last 12 months|GLUE: Year-over-year earnings per share growth rate for the last twelve months|CGEM (cullinanoncology.com) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Immuneering Inc. IMRX|Quarterly EPS earnings growth CCCC|Black Diamond Therapeutics - Year-over-year earnings per share growth for the last 12 months|Repare Therapeutics Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months KPTI|PPCB: Year-over-year net earnings per share growth for the last 12 months|Cyclacel Pharmaceuticals - Year-over-year earnings per share growth rate for the last twelve months|AADI: Quarterly EPS earnings growth|Aileron Therapeutics Inc - Year-over-year earnings per one share growth for the last 12 months|BPMC (Blueprint Medicines Corp.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months glycomimetics.com GLYC|Year-over-year earnings per share growth for the last twelve months SpringWorks (SWTX)